BioTrinity 2025
Syneos Health is a dedicated partner to the UK biotech sector, providing clinical, medical affairs and commercial solutions to partners at all stages of the asset development continuum.
We have vast experience working side by side with biotech companies in nearly every therapeutic category, in the UK and globally, and across all points along the product development continuum. We are uniquely positioned to address ever-evolving biotech dynamics and have an unrelenting commitment to your success.
Meet with Us
Our team will be at BioTrinity 2025! Find us at booth #1 or schedule a meeting to learn how you can have access to a truly cross-functional team of experts, fully committed to your success, providing a comprehensive and holistic approach to your asset needs.
Featured Sessions
Neuroscience Spotlight
April 1 | 10:00am BST
Oncology Spotlight
April 2 | 1:00pm BST
Juliette Roberts
Vice President and Global Head, Oncology Therapeutic Strategy & Innovation, Syneos Health
Wouter Bartholomeus
Executive Medical Director, Oncology & Hematology, Syneos Health
Related Content:
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
Insights
Syneos Health Podcast | Project Optimus Series
Syneos Health Podcast | Circulating Tumor DNA: Transforming Oncology Clinical Trials
Navigating Tumor-Agnostic Drug Development: Value, Challenges and Strategic Insights for Sponsors
Syneos Health Podcast | CNS Summit Series
Syneos Health Podcast | Can AI Help Get the Right Patients Into Alzheimer's Clinical Trials?
Understanding the Role of Placebo Response in Clinical Trials
Capabilities
Oncology Expertise at All Levels
End-to-End Expertise in Early Phase Oncology
Psychotherapeutics at Syneos Health
